What one share of Adicet Bio holds
We are a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. We are advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients.
Adicet Bio’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$10.54 |
|---|---|
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | −$9.05 |
| Cash and investments | $3.54 |
| Book value | $12.83 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$134.79 | $0.18 | −$44.01 | — | −$76.19 |
| 2018 | — | −$76.42 | $7.20 | −$156.60 | $0.00 | — |
| 2019 | — | −$210.48 | $8.00 | −$216.57 | $0.00 | −$448.07 |
| 2020 | — | −$80.17 | $2.16 | −$92.99 | $0.00 | — |
| 2021 | — | −$32.05 | $6.74 | −$33.13 | — | $122.05 |
| 2022 | — | −$27.18 | $6.54 | −$23.97 | — | $108.89 |
| 2023 | — | −$53.03 | $1.66 | −$36.50 | — | $62.93 |
| 2024 | — | −$21.33 | $0.20 | −$17.03 | — | $36.16 |
| 2025 | — | −$16.95 | $0.25 | −$14.07 | — | $16.61 |
Common questions about Adicet Bio
How much does one share of Adicet Bio earn?
Over the last 12 months, Adicet Bio lost $10.54 for each share.
Does Adicet Bio pay a dividend?
Adicet Bio didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Adicet Bio’s book value per share?
Adicet Bio’s book value is $12.83 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Adicet Bio have?
Each share of Adicet Bio has $3.54 of cash and investments, as of June 30, 2026.
What is Adicet Bio’s free cash flow per share?
−$9.05 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Adicet Bio bought back shares?
Adicet Bio’s share count rose about 2650% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.